Therapy For Success Revenue and Competitors

Dallas, TX USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Therapy For Success's estimated annual revenue is currently $675k per year.(i)
  • Therapy For Success's estimated revenue per employee is $135,000

Employee Data

  • Therapy For Success has 5 Employees.(i)
  • Therapy For Success grew their employee count by 0% last year.

Therapy For Success's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.9M32-9%N/AN/A
#2
$8.6M40-13%N/AN/A
#3
$10.4M4817%N/AN/A
#4
$42.2M14214%N/AN/A
#5
$10.6M4926%N/AN/A
#6
$8M376%N/AN/A
#7
$4M21-5%N/AN/A
#8
$8.9M41-7%N/AN/A
#9
$10.8M500%N/AN/A
#10
$8M37-24%N/AN/A
Add Company

What Is Therapy For Success?

We are currently hiring fully licensed speech-language pathologists. Part-time, full-time, make your own hours, build a caseload close to home. Call today! (972) 505-8335 We conduct one-on-one speech, language, and feeding therapy in the North Texas area in an environment that is familiar to the child such as the child's home or daycare. We only employ therapists whose experience and expertise ensure the highest quality of care and produce the best possible results. We are currently accepting highly qualified applicants to meet our growing demand for services.

keywords:N/A

N/A

Total Funding

5

Number of Employees

$675k

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Therapy For Success News

2022-04-20 - Outlook on the CAR-T Cell Therapies Industry - In-depth ...

Other barriers to therapeutic success include inadequate anti-tumor activity (in certain cases), antigen escape, restricted trafficking, and...

2022-04-20 - Lineage Announces a Fifth Cell Therapy Program: Allogeneic Photoreceptor Transplants for the Treatment of Diseases Which May Lead to Blindness

This latest program is part of our long-term planning for clinical and commercial success and serves as another example of the capability of our...

2022-03-30 - Gene Therapy Shows Modest Success for Genetic Blindness

SEATTLE – The latest data from a phase 3 clinical trial shows that gene therapy can counter visual degeneration associated with Leber...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$0.4M50%N/A
#2
$0.4M50%N/A
#3
$0.4M5-55%N/A
#4
$0.4M50%N/A
#5
$0.4M5-17%N/A